Respiratory medicine · 2026
Anxiety sensitivity in heart failure with preserved ejection fraction: Bias in dyspnea ratings and respiratory exercise response.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ritz Thomas, Kelley Niya, Balmain Bryce N, Tomlinson Andrew R, Abulimiti Abidan, Lutz Kevin C, Hynan Linda S, Levine Benjamin D, MacNamara James P, Sarma Satyam, Rosenfield David, Babb Tony G
Аннотация
BACKGROUND: Anxiety sensitivity, the fear of anxiety symptoms, is linked to elevated symptom reports in health and illness. Dyspnea on exertion, a dominant complaint in heart failure with preserved ejection fraction (HFpEF), could be affected by this personality characteristic. We examined whether patients with HFpEF and high anxiety sensitivity provide elevated dyspnea reports on global measures or in response to cardiopulmonary exercise testing under regular or pharmacological challenge conditions.
METHOD: Fifty-three patients (37 women, mean age 71.4 years) with HFpEF completed the Anxiety Sensitivity Index (ASI), Dyspnoea-12 questionnaire, modified Medical Research Council dyspnea rating (mMRC), and pulmonary function testing. They also performed 6-min constant-load cycling at 20 W and incremental cycling to exhaustion, with placebo or sublingual nitroglycerin in a single-blind, cross-over design. Ratings of perceived breathlessness and its unpleasantness, and ventilation and arterial blood gas measurements, were completed at rest, during the final minute of constant-load cycling, and immediately after incremental cycling.
RESULTS: ASI scores predicted Dyspnoea-12, but not mMRC scores. Across rest and exercise, PaCO2 and ventilatory efficiency was lower, and minute ventilation, dead space, and breathlessness ratings were higher, under nitroglycerin challenge. Under this condition, patients with higher ASI also reported more breathlessness across the exercise protocol, required greater V˙E to eliminate CO2 (V˙E/ V˙CO2), and had lower PaCO2 at pre-exercise while waiting for the nitroglycerin to take effect.
CONCLUSION: Overreporting of dyspnea and mild hyperventilation need to be considered when testing patients with HFpEF that are high in anxiety sensitivity in unusual medical situations that elicit symptoms.
METHOD: Fifty-three patients (37 women, mean age 71.4 years) with HFpEF completed the Anxiety Sensitivity Index (ASI), Dyspnoea-12 questionnaire, modified Medical Research Council dyspnea rating (mMRC), and pulmonary function testing. They also performed 6-min constant-load cycling at 20 W and incremental cycling to exhaustion, with placebo or sublingual nitroglycerin in a single-blind, cross-over design. Ratings of perceived breathlessness and its unpleasantness, and ventilation and arterial blood gas measurements, were completed at rest, during the final minute of constant-load cycling, and immediately after incremental cycling.
RESULTS: ASI scores predicted Dyspnoea-12, but not mMRC scores. Across rest and exercise, PaCO2 and ventilatory efficiency was lower, and minute ventilation, dead space, and breathlessness ratings were higher, under nitroglycerin challenge. Under this condition, patients with higher ASI also reported more breathlessness across the exercise protocol, required greater V˙E to eliminate CO2 (V˙E/ V˙CO2), and had lower PaCO2 at pre-exercise while waiting for the nitroglycerin to take effect.
CONCLUSION: Overreporting of dyspnea and mild hyperventilation need to be considered when testing patients with HFpEF that are high in anxiety sensitivity in unusual medical situations that elicit symptoms.